Jeffrey Jacob

Throughout his career, Mr. Jacob has created technology-based startup companies and supported the expansion of existing companies in both the physical and life sciences. In 2004 Mr. Jacob founded Systems Medicine Inc., a startup company applying systems biology, predictive pharmacogenomics, and clinical trial design innovations to the development of new cancer drugs. He served as the CEO until the Company was sold in 2007 (and remained Division CEO following the sale until late 2008). Mr. Jacob is a founding Board Member and previously served as the Chief Program Officer of the Critical Path Institute (C-Path) where he was responsible for creating initial programs. Between 1987 and 2004 Mr. Jacob worked with Research Corporation Technologies (RCT), most recently as its Senior Vice President. He oversaw RCT’s Commercialization Group responsible for directing technology assessment and commercialization activities. Mr. Jacob served as the CEO of a number of RCT-based startup companies and on its Investment Committee. Mr. Jacob has a Master’s degree in engineering and a Master’s degree in Technology and Policy from the Massachusetts Institute of Technology. His Bachelor’s degree in engineering was awarded from the University of Arizona.